M&A Deal Summary |
|
|---|---|
| Date | 2020-12-14 |
| Target | Renazorb |
| Sector | Medical Products |
| Buyer(s) | Unicycive Therapeutics |
| Sellers(s) | Spectrum Pharmaceuticals |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2016 |
| Sector | Life Science |
| Employees | 14 |
| Revenue | 1M USD (2023) |
Unicycive Therapeutics is a biotechnology company developing novel treatments across multiple therapeutic areas, currently focusing on kidney diseases. Unicycive Therapeutics is based in Los Altos, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Nevada M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Revenue | 26M USD (2023) |
Spectrum Pharmaceuticals is a biotechnology company focused on acquiring, developing and commercializing drug products with a primary focus in oncology and hematology. Spectrum Pharmaceuticals was founded in 1987 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Nevada M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-17 |
Talon Therapeutics
San Francisco, California, United States Talon Therapeutics (fka Hana Biosciences) is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees. |
Buy | - |
